Looks like you’re on the UK site. Choose another location to see content specific to your location

Home Industry News UCB and Pfizer welcome royalty to facility opening

UCB and Pfizer welcome royalty to facility opening

12th October 2007

UCB and Pfizer welcomed Belgium’s King Albert II to Ireland after he opened a new drug facility in Shannon that will act as a base for a drug collaboration between the two companies.

The manufacturing facility will develop Fesoterodine, which has been developed by UCB Group partner Schwarz Pharmaceuticals.

Licensed to Pfizer, Fesoterodine is a new drug that treats patients with an over-active bladder.

The facility will open in the first quarter of 2008 and additional upgrade projects at the Shannon facility are expected to be completed by the end of 2007.

Dr Roch Doliveux, UCB’s chief executive officer, confirmed the importance of the new facility but went on to emphasise that King Albert II’s state visit highlighted a greater need for cooperation between Belgium universities and innovative industries.

Following the company’s launch of Neupro and Xyal in the US in addition to its success in Ireland, Dr Roch Doliveux called on greater university funding, public research and educational improvements in Belgium and across Europe.

Earlier this month, UCB and Sanofi Aventis confirmed that Xyzal their new once-daily medication to treat allergies, is now available by prescription in the US.

We currently have 9 jobs available in Pharmacy industry, find your perfect one now.

Stay informed

Receive the latest industry news, Tips
and straight to your inbox.